Search - tctmd.com

Displaying 21 - 40 of 314

Sort: Relevancy | Date

News Conference News STS 2025

Amid Declining Use, Mechanical SAVR Valves Beat Bioprosthetic for Survival

Yael L. Maxwell

January 27, 2025

Surgeons Formalize Support for ESC’s Stance on Revascularization in CCS

News Daily News

Surgeons Formalize Support for ESC’s Stance on CCS Revascularization

Michael O'Riordan

January 20, 2025

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

News Daily News

New Platelet Function, Genetic Testing Consensus Seeks to Fill Gaps—Again

Yael L. Maxwell

November 27, 2024

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

Presentation TCT 2024

TCT 240: The Device Success Algorithm of EAPCI Prospectively Applied to the Three-Vessel Coronary Artery Disease Patients Undergoing State-of-the-Art Percutaneous Coronary Intervention in International Multivessel TALENT Randomized Trial

Presenter: Pruthvi C Revaiah

October 28, 2024

Presentation TCT 2024

TCT 246: Device Success Algorithm of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Prospectively Applied to the All-Comer PIONEER IV Trial

Presenter: Asahi Oshima

October 28, 2024

News Conference News EACTS 2024

At EACTS 2024, Surgeons and Cardiologists Move Past EXCEL Firestorm

Yael L. Maxwell

October 22, 2024

News Conference News EACTS 2024

MACE in CV Trials: Has the Outcome Outlived Its Role?

Yael L. Maxwell

October 11, 2024

News Conference News ESC 2024

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Michael O'Riordan

September 17, 2024

News Conference News ESC 2024

REC-CAGEFREE I: DCB Fails to Match Up to DES for De Novo CAD

Todd Neale

September 09, 2024

News Conference News ESC 2024

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

Michael O'Riordan

September 01, 2024

News Daily News

Genetic Tests for Predicting Clopidogrel Response Gain Traction: AHA

Caitlin E. Cox

June 25, 2024

News Opinion CV Team Dispatch

June 2024 Dispatch for the CV Team

L.A. McKeown

June 01, 2024

News Conference News EuroPCR 2024

POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival

Yael L. Maxwell

May 22, 2024

News Conference News EuroPCR 2024

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

Yael L. Maxwell

May 17, 2024

News Conference News EuroPCR 2024

NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

Michael O'Riordan

May 14, 2024

News Conference News EHRA 2024

Preventive VT Ablation Before ICD Helps High-risk Ischemic Cardiomyopathy Patients

Todd Neale

April 10, 2024

News Daily News

Intravascular Imaging Lowers Risk of MACE at 1 Year in Left Main PCI

Michael O'Riordan

March 26, 2024

News Daily News

Even After Multivessel or LM PCI, Routine Stress Testing Adds Nothing

Yael L. Maxwell

March 01, 2024

Advertisement

Amid Declining Use, Mechanical SAVR Valves Beat Bioprosthetic for Survival

Surgeons Formalize Support for ESC’s Stance on CCS Revascularization

Top Coronary Artery Disease News in 2024

New Platelet Function, Genetic Testing Consensus Seeks to Fill Gaps—Again

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

TCT 240: The Device Success Algorithm of EAPCI Prospectively Applied to the Three-Vessel Coronary Artery Disease Patients Undergoing State-of-the-Art Percutaneous Coronary Intervention in International Multivessel TALENT Randomized Trial

TCT 246: Device Success Algorithm of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Prospectively Applied to the All-Comer PIONEER IV Trial

At EACTS 2024, Surgeons and Cardiologists Move Past EXCEL Firestorm

MACE in CV Trials: Has the Outcome Outlived Its Role?

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

REC-CAGEFREE I: DCB Fails to Match Up to DES for De Novo CAD

NOTION-3: PCI Before TAVI Lowers MACE Risks in Patients With Significant CAD

Genetic Tests for Predicting Clopidogrel Response Gain Traction: AHA

June 2024 Dispatch for the CV Team

POLMIDES: Hybrid Revascularization Bests CABG For 10-Year Survival

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

NOW PUBLISHED - Latest TAVI vs Surgery Trial Raises Eyebrows in Aortic Stenosis Plus CAD

Preventive VT Ablation Before ICD Helps High-risk Ischemic Cardiomyopathy Patients

Intravascular Imaging Lowers Risk of MACE at 1 Year in Left Main PCI

Even After Multivessel or LM PCI, Routine Stress Testing Adds Nothing

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content